Vertex Tumbles As It Stops Testing On Protein Deficiency TreatmentInvestors Business Daily • 10/14/20
Vertex Looks To Target 10% Of Cystic Fibrosis Population Not Yet Achieved By Its Current CFTR ModulatorsSeeking Alpha • 10/12/20